Crossmark

FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy

Crossref DOI link: https://doi.org/10.1016/j.drup.2020.100719

Published Print: 2020-12

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Drożdżal, Sylwester

Rosik, Jakub

Lechowicz, Kacper

Machaj, Filip

Kotfis, Katarzyna

Ghavami, Saeid

Łos, Marek J.
License Information

Text and Data Mining valid from 2020-12-01
More Information

This article is maintained by: Elsevier

Article Title: FDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy

Journal Title: Drug Resistance Updates

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.drup.2020.100719

Content Type: article

Copyright: Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved.